Business Context and Reporting Period
This Form 8-K Current Report was filed by Globalstar, Inc. on October 14, 2013. The filing details the entry into a Material Definitive Agreement and the unregistered sale of equity securities involving Thermo Funding Company LLC ("TFC") and Thermo Funding II LLC ("TFII"), collectively "Thermo," entities controlled by the Company's Chairman and CEO, James Monroe III.
Key Financial Metrics and Transaction Details
- Investment Commitment: Thermo committed to invest up to $85 million in Globalstar equity securities.
- Capital Raised to Date: $12.5 million total ($6.0 million on July 29, 2013, and $6.5 million on August 19, 2013).
- Shares Issued: 11,538,461 shares of non-voting common stock issued for the initial $6.0 million investment.
- Stock Price Range: Voting common stock traded between $0.57 and $0.65 per share during the July 29 to August 19, 2013 period.
- Failed Third-Party Efforts: The Company was unable to secure commitments from third-party investors for at least $20 million at a price of $0.52 per share.
Material Changes and Agreement Terms
The Company entered into a Common Stock Purchase and Option Agreement with Thermo. Key terms include:
- Additional Purchase Obligation: Thermo agreed to purchase an additional 38,461,538 shares (representing the $6.5 million August investment plus an incremental $13.5 million) as requested by the special committee through November 28, 2013.
- Option to Purchase: Thermo has the option to purchase up to $11.5 million of additional non-voting common stock at a price equal to 85% of the average closing price of voting common stock on the ten trading days preceding the request, valid until December 26, 2013.
- Approval: Terms were approved on October 14, 2013, by a special committee of unaffiliated directors represented by independent legal counsel, who deemed the terms fair and in the best interests of the Company.
Guidance, Risks, and Contingencies
The filing does not provide specific financial guidance, revenue outlook, or management commentary regarding future operational performance. The primary contingency noted is the reliance on Thermo as the sole willing investor for the $20 million tranche after third-party fundraising efforts failed. The shares sold are classified as "restricted securities" and cannot be transferred without registration or an applicable exemption.
Investor Verification Checklist
- Verify the exact number of shares issued for the $6.5 million August 19 investment, as the text specifies the total shares for the combined $20 million tranche but does not explicitly isolate the August tranche share count.
- Confirm the current status of the incremental $13.5 million funding request and whether it has been executed as of the filing date.
- Review the voting rights structure, noting that the shares purchased by Thermo are non-voting common stock.
- Assess the impact of the 85% discount pricing mechanism on future dilution if the option to purchase up to $11.5 million is exercised.